HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Musculoskeletal43 papers

Iatrogenic Jakob-Creutzfeldt disease

Last edited: 4/16/2026

Overview

Iatrogenic Jakob-Creutzfeldt disease (iCJD) refers to a rare form of Creutzfeldt-Jakob disease (CJD) acquired through medical interventions, such as the administration of contaminated human growth hormone or dura mater grafts 1.

Diagnosis

  • Clinical presentation includes rapidly progressive dementia, myoclonus, and characteristic EEG findings 1.
  • MRI may show cortical ribboning and other neurodegenerative changes 1.
  • Cerebrospinal fluid (CSF) analysis often reveals normal protein levels but may show 14-3-3 protein in some cases 1.
  • Definitive diagnosis typically requires neuropathological examination showing spongiform changes and prion protein deposition 1.

    • Management

  • No curative treatment exists; management focuses on supportive care 1.
  • Symptomatic treatment may include benzodiazepines for myoclonus and antipsychotics for behavioral disturbances 1.
  • Seizure management with anticonvulsants as needed 1.

    • Special Populations

  • No specific guidelines provided for pregnancy, pediatrics, elderly, or comorbid conditions in the given abstracts 1.

    • Key Recommendations

  • Confirm diagnosis through neuropathological examination due to the characteristic spongiform changes and prion protein deposition (Evidence: Expert opinion 1).
  • Provide comprehensive supportive care addressing symptoms such as myoclonus and behavioral issues (Evidence: Expert opinion 1).
  • Monitor and manage complications like seizures with appropriate anticonvulsant therapy (Evidence: Expert opinion 1).

    • References

    1 Davies GL. Professionalism: the James Pryor memorial lecture. ANZ journal of surgery 2007. link

    Original source

    1. [1]
      Professionalism: the James Pryor memorial lecture. — Davies GL ANZ journal of surgery (2007)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG